from the ANN:
Sue Fletcher, PYC’s CSO: ‘I am very excited to expand my involvement with PYC. The
development of our lead program and broader retinal pipeline has been incredibily rewarding. I
look forward to leading the advancement of our retinal programs in parallel to expanding our
approach to the central nervous system, where I believe our technology can have life-changing
impact for patients.’
Ann: Appointment of world-renowned Chief Scientific Officer, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.035(2.75%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.22 | $162.1K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3818 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |